₹24.59
▲ +0.59 +2.46%
As of 27 Oct 2026 · delayed
BSE Listed
Medico Intercontinental Limited (539938)
Volume: 1,427Avg Vol 1W: 1,071Avg Vol 1M: 2,22052W Range:₹20.61₹43
Key Ratios
Checked 8h agoMarket Cap₹25 Cr
Current Price₹24.59
Previous Close₹24
High / Low (52w)₹43 / ₹20.61
Volume1,427
Avg Vol (1W)1,071
Avg Vol (1M)2,220
Stock P/E—
Book Value₹46.89
Dividend Yield0%
ROE-6.83%
ROA-10.78%
Revenue (TTM)—
Revenue Growth—
Profit Margin-475.73%
Total Debt—
Shares Outstanding1 Cr
Face Value—
EPS (TTM)₹0
P/B0.52
Debt / Equity0.87
50 DMA₹25.84
200 DMA₹28.49
Day change+2.46%
Price Chart
₹24.59▼ 28.48% · 1Y
2025-10-272026-10-27
20-day avg volume: 2K shares
Pros
- Company is almost debt-free.
- Stock trades below its book value.
Cons
- Revenue fell 83% YoY.
Quarterly Results
| Metric | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹36 Cr | ₹18 Cr | ₹21 Cr | ₹21 Cr | ₹20 Cr | ₹20 Cr | ₹22 Cr | ₹21 Cr |
| EBITDA | ₹3 Cr | ₹2 Cr | ₹2 Cr | ₹0 Cr | ₹-2 Cr | ₹1 Cr | ₹0 Cr | ₹-2 Cr |
| Net Profit | ₹2 Cr | ₹1 Cr | ₹1 Cr | ₹-1 Cr | ₹-2 Cr | ₹0 Cr | ₹-1 Cr | ₹-1 Cr |
| EPS | — | — | — | — | — | — | — | — |
Profit & Loss (Annual)
| Metric | Mar 2025 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹15 Cr | ₹96 Cr | ₹13 Cr | ₹12 Cr | ₹13 Cr | ₹85 Cr | ₹16 Cr | ₹14 Cr |
| EBITDA | ₹1 Cr | ₹8 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹-1 Cr | ₹1 Cr | ₹1 Cr |
| Net Profit | ₹1 Cr | ₹5 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹-3 Cr | ₹0 Cr | ₹1 Cr |
| EPS | — | 5.06 | — | — | — | -3.2 | — | — |
Balance Sheet
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | ₹9 Cr | ₹36 Cr | ₹31 Cr | ₹32 Cr | ₹59 Cr | ₹56 Cr | ₹77 Cr | ₹117 Cr |
| Total Liabilities | ₹5 Cr | ₹30 Cr | ₹21 Cr | ₹19 Cr | ₹18 Cr | ₹11 Cr | ₹27 Cr | ₹85 Cr |
| Equity | ₹4 Cr | ₹6 Cr | ₹10 Cr | ₹13 Cr | ₹41 Cr | ₹45 Cr | ₹50 Cr | ₹32 Cr |
| Total Debt | — | — | — | — | — | — | — | — |
Cash Flow
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating | ₹1 Cr | ₹-9 Cr | ₹7 Cr | ₹5 Cr | ₹-9 Cr | ₹7 Cr | ₹-4 Cr | ₹19 Cr |
| Investing | ₹0 Cr | ₹0 Cr | ₹-1 Cr | ₹-1 Cr | ₹-5 Cr | ₹-9 Cr | ₹-5 Cr | ₹2 Cr |
| Financing | ₹0 Cr | ₹13 Cr | ₹-5 Cr | ₹-1 Cr | ₹20 Cr | ₹0 Cr | ₹10 Cr | ₹-16 Cr |
| Free Cash Flow | ₹1 Cr | ₹-9 Cr | ₹7 Cr | ₹5 Cr | ₹-9 Cr | ₹7 Cr | ₹-4 Cr | ₹19 Cr |
Shareholding
Promoter 58.51% Institutions 0% Public 41.49%
Efficiency & Working Capital
ROCE-1%
Interest Coverage-0.1
Dividend Payout—
Debtor Days119 d
Inventory Days65 d
Payable Days61 d
Cash Conversion Cycle123 d
Working Capital Days184 d
Shareholding Details
As of 2026-09-30
Promoter58.5%
FII0%
DII0%
Institutions0%
Public41.5%
Promoter Pledge0%
No. of Shareholders3,446
Shareholding Pattern
Quarterly — figures in %. Latest 12 quarters.
| Period | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sept 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 55.1% | 55.1% | 55.1% | 55.1% | 55.2% | 55.2% | 55.2% | 55.2% | 57.1% | 57.1% | 58.5% | 58.5% |
| FIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 44.9% | 44.9% | 44.9% | 44.9% | 44.8% | 44.8% | 44.8% | 44.8% | 42.9% | 42.9% | 41.5% | 41.5% |
| Promoter Pledge | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| No. of Shareholders | 1,119 | 3,499 | 3,465 | 3,577 | 3,759 | 3,731 | 3,696 | 3,625 | 3,575 | 3,499 | 3,489 | 3,446 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202603 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| Shah Samir | Shareholding of Promoter and Promoter Group | 47.8% | 47,76,999 |
| Dilipkumar Bhogilal Shah | Shareholding of Promoter and Promoter Group | 10.7% | 10,74,397 |
| Dd Master Huf . | Public Shareholding | 1.2% | 1,23,575 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| Tanvi Shah | Chairman & Non Executive Dir. | 2025 |
| Samir Shah | Executive Director & MD | 2025 |
| Ankur Dave | Independent Non Exe. Director | 2025 |
| Priyank Lalitbhai Sancheti | Independent Non Exe. Director | 2025 |
| Swati Vikramkumar Shah | Non Executive Director | 2025 |
| Parshwa Kaushal Shah | Independent Non Exe. Director | 2025 |
| Puneeta Sharma | Company Sec. & Compli. Officer | 2025 |
Segments — Product
| Segment | Revenue | Share |
|---|---|---|
| Trading | ₹57 Cr | 100% |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2026 | ₹10 | 20 | 10 | 10 |
Corporate Actions
| Type | Date | Value | Remark |
|---|---|---|---|
| forthcoming | 2026-08-14 | Board Meetings | — |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2026 | 48 | 0 | 5 | 1 | 10 | 63 |
| 2026 | 30 | 0 | 1 | 0 | 0 | 31 |
| 2026 | 10 | 0 | 0 | 1 | 4 | 16 |
Insider / Designated-Person Trades
2 recent disclosure(s)
SAMIR DILIPKUMAR SHAHAcquisition · 1,36,886
SAMIR DILIPKUMAR SHAHAcquisition · 1,97,285
Substantial Acquisitions (SAST)
1 disclosure(s)
Market24/12/2025 · 1,97,285
Company Information
🌐 www.medicointercontinental.com ↗
📍 213 2nd Floor, Raheja Chambers Nariman Point, Mumbai, Maharashtra, 400021
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Dalmia Industrial Development Ltd.Svarnim Trade Udyog LimitedNagarjuna Fertilizers & ChemicalsShanti Educational InitiativesRotographics (India) LimitedLikhami Consulting LimitedYash Chemex LimitedBazel International LimitedJindal Leasefin LimitedTaaL TechMahanagar GasZeal Aqua LimitedAll “53” stocks →
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search
